- Investor Overview
- Stock Information
- Corporate Governance
- Financial Information
- Investor FAQs
- Contact Investor Relations
Jackie Marcus or Chris Hodges
Alpha IR Group
Phone: (312) 445-2870
|View printer-friendly version|
|Insys Therapeutics, Inc. Releases Statement on Payor Interactions|
Insys, in concert with its business partners, is dedicated to helping patients navigate the complex payor environment that exists for patients as they seek to access the Insys products that their practicing health care providers have deemed appropriate or necessary for their treatment. As part of this endeavor, Insys is committed to establishing long-term partnerships in the healthcare community with public and private payors and operating with integrity and ethical standards that cultivate a culture of trust and transparency.
We believe that in the spirit of accountability, we have taken, and will continue to take, appropriate steps to learn from the past and to ensure that appropriate protocols and policies are in place at our Company. Where appropriate, Insys will vigorously advocate for fair patient access to medications, as well as vigorously defend itself within the legal and regulatory proceedings available to the Company.
SUBSYS® and SYNDROS™ are trademarks of
NOTE: All trademarks and registered trademarks are the property of their respective owners.